Exane Derivatives’s Meta Platforms (Facebook) META Stock Holding History

Exane Derivatives’s Portfolio META Stock Details META Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.37M	Buy	8,517 +1,420	+20%	+$274K	0.79%	28
2022 Q1	$1.58M	Buy	7,097 +759	+12%	+$190K	0.44%	45
2021 Q4	$2.13M	Buy	6,338 +1,821	+40%	+$605K	0.52%	33
2021 Q3	$1.53M	Buy	4,517 +442	+11%	+$159K	0.37%	55
2021 Q2	$1.43M	Sell	4,075 -163	-4%	-$52.3K	0.33%	64
2021 Q1	$1.25M	Buy	4,238 +656	+18%	+$177K	0.36%	66
2020 Q4	$978K	Buy	3,582 +3,129	+691%	+$858K	0.29%	89
2020 Q3	$119K	Buy	+453	New	+$117K	0.03%	280
2018 Q4	–	Sell	-2,604	Closed	-$434K	–	716
2018 Q3	$434K	Sell	2,604 -167	-6%	-$30.2K	0.08%	169
2018 Q2	$542K	Sell	2,771 -12,495	-82%	-$2.26M	0.09%	176
2018 Q1	$2.34M	Buy	15,266 +11,878	+351%	+$2.13M	0.47%	45
2017 Q4	$598K	Sell	3,388 -10,412	-75%	-$1.84M	0.1%	149
2017 Q3	$2.36M	Buy	13,800 +11,485	+496%	+$1.92M	0.44%	38
2017 Q2	$349K	Sell	2,315 -18,283	-89%	-$2.72M	0.08%	162
2017 Q1	$2.93M	Sell	20,598 -17,089	-45%	-$2.28M	0.66%	39
2016 Q4	$4.34M	Sell	37,687 -29,572	-44%	-$3.63M	0.86%	17
2016 Q3	$8.63M	Buy	67,259 +59,973	+823%	+$7.45M	1.29%	12
2016 Q2	$833K	Buy	7,286 +1,610	+28%	+$186K	0.14%	98
2016 Q1	$648K	Sell	5,676 -189,456	-97%	-$20M	0.09%	117
2015 Q4	$20.4M	Buy	195,132 +164,924	+546%	+$16.9M	2.8%	3
2015 Q3	$2.72M	Buy	30,208 +1,473	+5%	+$135K	0.34%	53
2015 Q2	$2.46M	Buy	+28,735	New	+$2.35M	0.27%	58
2015 Q1	–	Sell	-30,092	Closed	-$2.36M	–	546
2014 Q4	$2.35M	Buy	+30,092	New	+$2.3M	0.33%	61

Other funds holding META

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's META Position: Q2 2022 in Review

Exane Derivatives increased its Meta Platforms (Facebook) (META) stake by 20% in Q2 2022, buying an estimated $274K and bringing the position to 8,517 shares worth $1.37M. The position accounts for 0.79% of the portfolio, ranked #28.

Exane Derivatives first reported a position in META in Q4 2014 and has held it in 23 quarters since. The position peaked at $20.4M in Q4 2015. 3,075 funds tracked by Wall St. Rank hold META as of Q2 2022.

Exane Derivatives held 8,517 shares of Meta Platforms (Facebook) worth $1.37M as of Q2 2022.
Exane Derivatives bought 1,420 Meta Platforms (Facebook) shares in Q2 2022, an estimated $274K.
Meta Platforms (Facebook) made up 0.79% of Exane Derivatives's portfolio in Q2 2022, its #28 holding.
Exane Derivatives first reported a position in Meta Platforms (Facebook) in Q4 2014 and has held it in 23 quarters since.
Exane Derivatives's Meta Platforms (Facebook) position peaked at $20.4M in Q4 2015.
3,075 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.